{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:13:40Z","timestamp":1783653220226,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04940-0","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T07:55:09Z","timestamp":1779177309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristic pathological findings of achalasia behind unresectable esophageal cancer with pathological complete response after chemotherapy: a case report and literature review"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9438-9445","authenticated-orcid":false,"given":"Koichi","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Asakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Furuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Motoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taigo","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Nishiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuto","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Inaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Kinami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itasu","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"9911","key":"4940_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0140-6736(13)60651-0","volume":"383","author":"GE Boeckxstaens","year":"2014","unstructured":"Boeckxstaens GE, Zaninotto G, Richter JE. Achalasia Lancet. 2014;383(9911):83\u201393.","journal-title":"Achalasia Lancet"},{"issue":"6","key":"4940_CR2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00268-001-0026-3","volume":"25","author":"BL Brucher","year":"2001","unstructured":"Brucher BL, Stein HJ, Bartels H, Feussner H, Siewert JR. Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg. 2001;25(6):745\u20139.","journal-title":"World J Surg"},{"issue":"4","key":"4940_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/00000478-199404000-00001","volume":"18","author":"JR Goldblum","year":"1994","unstructured":"Goldblum JR, Whyte RI, Orringer MB, Appelman HD. Achalasia. A morphologic study of 42 resected specimens. Am J Surg Pathol. 1994;18(4):327\u201337.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"4940_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1440-1746.2006.04250.x","volume":"21","author":"I Gockel","year":"2006","unstructured":"Gockel I, Bohl JR, Doostkam S, Eckardt VF, Junginger T. Spectrum of histopathologic findings in patients with achalasia reflects different etiologies. J Gastroenterol Hepatol. 2006;21(4):727\u201333.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"4940_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1442-2050.2005.00478.x","volume":"18","author":"AP Kjellin","year":"2005","unstructured":"Kjellin AP, Ost AE, Pope CE 2. Histology of esophageal mucosa from patients with achalasia. Dis Esophagus. 2005;18(4):257\u201361.","journal-title":"Dis Esophagus"},{"issue":"4","key":"4940_CR6","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1007\/s13311-021-01142-2","volume":"18","author":"H Esther","year":"2021","unstructured":"Esther H, Bae MK, Greenwald, Ann G, Schwartz. Chemotherapy-induced peripheral neuropathy: Mechanisms and therapeutic avenues. Neurotherapeutics. 2021;18(4):2384\u201396.","journal-title":"Neurotherapeutics"},{"issue":"11","key":"4940_CR7","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/s41395-018-0240-3","volume":"113","author":"SJ Spechler","year":"2018","unstructured":"Spechler SJ, Konda V, Souza R. Can eosinophilic esophagitis cause achalasia and other esophageal motility disorders? Am J Gastroenterol. 2018;113(11):1594\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"4940_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s10388-020-00720-1","volume":"17","author":"D Schizas","year":"2020","unstructured":"Schizas D, Theochari NA, Katsaros I, Mylonas KS, Triantafyllou T, Michalinos A, Kamberoglou D, Tsekrekos A, Rouvelas I. Pseudoachalasia: a systematic review of the literature. Esophagus. 2020;17(3):216\u201322.","journal-title":"Esophagus"},{"issue":"4","key":"4940_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/00365520510012118","volume":"40","author":"I Gockel","year":"2005","unstructured":"Gockel I, Eckardt VF, Schmitt T, Junginger T. Pseudoachalasia: a case series and analysis of the literature. Scand J Gastroenterol. 2005;40(4):378\u201385.","journal-title":"Scand J Gastroenterol"},{"key":"4940_CR10","doi-asserted-by":"crossref","unstructured":"Nasa M, Bhansali S, Choudhary NS, Sud R. Uncommon cause of dysphagia: paraneoplastic achalasia. BMJ Case Rep 2018, 2018.","DOI":"10.1136\/bcr-2017-223929"},{"issue":"3","key":"4940_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.canrad.2020.09.006","volume":"25","author":"V Vitton","year":"2021","unstructured":"Vitton V, Andrianjafy C, Luciano L, Gonzalez JM, Padovani L. Radio-induced esophageal motility disorders: An unrecognized diagnosis. Cancer Radiother. 2021;25(3):249\u201353.","journal-title":"Cancer Radiother"},{"issue":"2","key":"4940_CR12","doi-asserted-by":"publisher","first-page":"188291","DOI":"10.1016\/j.bbcan.2019.04.007","volume":"1872","author":"K Nesteruk","year":"2019","unstructured":"Nesteruk K, Spaander MCW, Leeuwenburgh I, Peppelenbosch MP, Fuhler GM. Achalasia and associated esophageal cancer risk: What lessons can we learn from the molecular analysis of Barrett\u2019s-associated adenocarcinoma? Biochim Biophys Acta Rev Cancer. 2019;1872(2):188291.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"4","key":"4940_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.14309\/ajg.0000000000002591","volume":"119","author":"EE Low","year":"2024","unstructured":"Low EE, Demb J, Shah SC, Liu L, Bustamante R, Yadlapati R, Gupta S. Risk of Esophageal Cancer in Achalasia: A Matched Cohort Study Using the Nationwide Veterans Affairs Achalasia Cohort. Am J Gastroenterol. 2024;119(4):635\u201345.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"4940_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/dote\/dox072","volume":"30","author":"F Tustumi","year":"2017","unstructured":"Tustumi F, Bernardo WM, da Rocha JRM, Szachnowicz S, Seguro FC, Bianchi ET, Sallum RAA, Cecconello I. Esophageal achalasia: a risk factor for carcinoma. A systematic review and meta-analysis. Dis Esophagus. 2017;30(10):1\u20138.","journal-title":"Dis Esophagus"},{"issue":"4","key":"4940_CR15","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00535-021-01763-6","volume":"56","author":"H Sato","year":"2021","unstructured":"Sato H, Terai S, Shimamura Y, Tanaka S, Shiwaku H, Minami H, Sato C, Ogawa R, Yokomichi H, Inoue H. Achalasia and esophageal cancer: a large database analysis in Japan. J Gastroenterol. 2021;56(4):360\u201370.","journal-title":"J Gastroenterol"},{"issue":"9","key":"4940_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12032-014-0188-0","volume":"31","author":"V Noronha","year":"2014","unstructured":"Noronha V, Joshi A, Jandyal S, Jambhekar N, Prabhash K. High pathologic complete remission rate from induction docetaxel, platinum and fluorouracil (DCF) combination chemotherapy for locally advanced esophageal and junctional cancer. Med Oncol. 2014;31(9):188.","journal-title":"Med Oncol"},{"issue":"11","key":"4940_CR17","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/bjc.2016.350","volume":"115","author":"T Yokota","year":"2016","unstructured":"Yokota T, Kato K, Hamamoto Y, Tsubosa Y, Ogawa H, Ito Y, Hara H, Ura T, Kojima T, Chin K, et al. Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer. Br J Cancer. 2016;115(11):1328\u201334.","journal-title":"Br J Cancer"},{"issue":"10447","key":"4940_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(24)00745-1","volume":"404","author":"K Kato","year":"2024","unstructured":"Kato K, Machida R, Ito Y, Daiko H, Ozawa S, Ogata T, Hara H, Kojima T, Abe T, Bamba T, et al. Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial. Lancet. 2024;404(10447):55\u201366.","journal-title":"Lancet"},{"issue":"10302","key":"4940_CR19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(21)01234-4","volume":"398","author":"JM Sun","year":"2021","unstructured":"Sun JM, Shen L, Shah MA, Enzinger P, Adenis A, Doi T, Kojima T, Metges JP, Li Z, Kim SB, et al. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study. Lancet. 2021;398(10302):759\u201371.","journal-title":"Lancet"},{"issue":"5","key":"4940_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa2111380","volume":"386","author":"Y Doki","year":"2022","unstructured":"Doki Y, Ajani JA, Kato K, Xu J, Wyrwicz L, Motoyama S, Ogata T, Kawakami H, Hsu CH, Adenis A, et al. Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma. N Engl J Med. 2022;386(5):449\u201362.","journal-title":"N Engl J Med"},{"issue":"5","key":"4940_CR21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1470-2045(23)00108-0","volume":"24","author":"J Xu","year":"2023","unstructured":"Xu J, Kato K, Raymond E, Hubner RA, Shu Y, Pan Y, Park SR, Ping L, Jiang Y, Zhang J, et al. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study. Lancet Oncol. 2023;24(5):483\u201395.","journal-title":"Lancet Oncol"},{"key":"4940_CR22","doi-asserted-by":"crossref","unstructured":"Matsuda S, Tsushima T, Kawakubo H, Hironaka S, Tsubosa Y, Sakanaka K, Oguma J, Kadowaki S, Tsunoda S, Hara H et al. Safety and efficacy of conversion therapy for metastatic esophageal cancer: exploratory analysis of JCOG1314. Esophagus 2026, 23(1):111-9.","DOI":"10.1007\/s10388-025-01163-2"},{"issue":"5","key":"4940_CR23","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1245\/s10434-024-14960-3","volume":"31","author":"K Sugimura","year":"2024","unstructured":"Sugimura K, Tanaka K, Sugase T, Momose K, Kanemura T, Yamashita K, Makino T, Shiraishi O, Motoori M, Yamasaki M, et al. Clinical Impact of Conversion Surgery After Induction Therapy for Esophageal Cancer with Synchronous Distant Metastasis: A Multi-institutional Retrospective Study. Ann Surg Oncol. 2024;31(5):3437\u201347.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"4940_CR24","doi-asserted-by":"publisher","first-page":"9270","DOI":"10.1245\/s10434-025-18042-w","volume":"32","author":"K Tanaka","year":"2025","unstructured":"Tanaka K, Sugimura K, Matsuura N, Shiraishi O, Momose K, Yamashita K, Sugase T, Kanemura T, Makino T, Takeno A, et al. Outcome of Conversion Surgery After Induction Therapy for Esophageal Cancer with Synchronous Para-Aortic Lymph Node Metastasis: A Multi-institutional Retrospective Study. Ann Surg Oncol. 2025;32(12):9270\u201380.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"4940_CR25","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/S2468-1253(25)00207-9","volume":"10","author":"H Takeuchi","year":"2025","unstructured":"Takeuchi H, Machida R, Ando M, Tsubosa Y, Kikuchi H, Kawakubo H, Noma K, Ueno M, Tsushima T, Bamba T, et al. Thoracoscopic versus open oesophagectomy for patients with oesophageal cancer (JCOG1409 MONET): a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial. Lancet Gastroenterol Hepatol. 2025;10(12):1104\u201316.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"4940_CR26","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1097\/SLA.0000000000005023","volume":"275","author":"Y Yang","year":"2022","unstructured":"Yang Y, Li B, Yi J, Hua R, Chen H, Tan L, Li H, He Y, Guo X, Sun Y, et al. Robot-assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma: Early Results of a Multicenter Randomized Controlled Trial: the RAMIE Trial. Ann Surg. 2022;275(4):646\u201353.","journal-title":"Ann Surg"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04940-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04940-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04940-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:22:28Z","timestamp":1783650148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04940-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4940"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04940-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We obtained approval from the Institutional Ethics Committee of the Kanazawa university hospital (Approval number: 2019\u2009\u2212\u2009295). Consent to Participate declaration: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and any accompanying images. A copy of the written consent is available for review by the editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"436"}}